These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 17380276)
21. [Abnormal expression of pyruvate dehydrogenase on bile ducts opens new fields in the pathogenesis of primary biliary cirrhosis]. Nakanuma Y; Yasoshima M; Morita T; Gershwin ME Nihon Rinsho; 1995 May; 53(5):1287-96. PubMed ID: 7602793 [TBL] [Abstract][Full Text] [Related]
22. Etiopathogenesis of primary biliary cirrhosis. Lleo A; Invernizzi P; Mackay IR; Prince H; Zhong RQ; Gershwin ME World J Gastroenterol; 2008 Jun; 14(21):3328-37. PubMed ID: 18528930 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Hashimoto E; Lindor KD; Homburger HA; Dickson ER; Czaja AJ; Wiesner RH; Ludwig J Mayo Clin Proc; 1993 Nov; 68(11):1049-55. PubMed ID: 8231268 [TBL] [Abstract][Full Text] [Related]
24. Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis. Sasaki M; Kakuda Y; Miyakoshi M; Sato Y; Nakanuma Y J Clin Pathol; 2014 Jun; 67(6):470-6. PubMed ID: 24407434 [TBL] [Abstract][Full Text] [Related]
25. Analysis of T-cell receptor beta of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis. Ichiki Y; Shimoda S; Hara H; Shigematsu H; Nakamura M; Hayashida K; Ishibashi H; Niho Y Hepatology; 1997 Sep; 26(3):728-33. PubMed ID: 9303504 [TBL] [Abstract][Full Text] [Related]
26. Current concepts in the pathogenesis of primary biliary cirrhosis. Charatcharoenwitthaya P; Lindor KD Ann Hepatol; 2005; 4(3):161-75. PubMed ID: 16177655 [TBL] [Abstract][Full Text] [Related]
27. Approaches to the pathogenesis of primary biliary cirrhosis through animal models. Concepcion AR; Medina JF Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):21-8. PubMed ID: 21862437 [TBL] [Abstract][Full Text] [Related]
28. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Long SA; Van de Water J; Gershwin ME Autoimmun Rev; 2002 Feb; 1(1-2):37-42. PubMed ID: 12849056 [TBL] [Abstract][Full Text] [Related]
29. Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis-associated autoantigen, pyruvate dehydrogenase complex. Jones DE; Palmer JM; Bennett K; Robe AJ; Yeaman SJ; Robertson H; Bassendine MF; Burt AD; Kirby JA Lab Invest; 2002 Feb; 82(2):211-9. PubMed ID: 11850534 [TBL] [Abstract][Full Text] [Related]
30. Autoimmune tests in primary biliary cirrhosis. Strassburg CP; Manns MP Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):585-99. PubMed ID: 10976016 [TBL] [Abstract][Full Text] [Related]
31. Is primary biliary cirrhosis a model autoimmune disease? Ichiki Y; Shimoda S; Ishibashi H; Gershwin ME Autoimmun Rev; 2004 Jun; 3(4):331-6. PubMed ID: 15246030 [TBL] [Abstract][Full Text] [Related]
32. Innate immunity in the pathogenesis of cholangiopathy: a recent update. Harada K; Nakanuma Y Inflamm Allergy Drug Targets; 2012 Dec; 11(6):478-83. PubMed ID: 22920631 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host. Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358 [TBL] [Abstract][Full Text] [Related]
34. The immune response to mitochondrial autoantigens. Ishibashi H; Shimoda S; Gershwin ME Semin Liver Dis; 2005 Aug; 25(3):337-46. PubMed ID: 16143949 [TBL] [Abstract][Full Text] [Related]
35. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. Malmborg AC; Shultz DB; Luton F; Mostov KE; Richly E; Leung PS; Benson GD; Ansari AA; Coppel RL; Gershwin ME; Van de Water J J Autoimmun; 1998 Oct; 11(5):573-80. PubMed ID: 9802945 [TBL] [Abstract][Full Text] [Related]
36. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis. Surh CD; Ahmed-Ansari A; Gershwin ME J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773 [TBL] [Abstract][Full Text] [Related]
37. Nonsuppurative cholangitis is induced in neonatally thymectomized mice: a possible animal model for primary biliary cirrhosis. Kobashi H; Yamamoto K; Yoshioka T; Tomita M; Tsuji T Hepatology; 1994 Jun; 19(6):1424-30. PubMed ID: 8188172 [TBL] [Abstract][Full Text] [Related]
38. Ductular expression of autoantigens in primary biliary cirrhosis. Joplin R; Gershwin ME Semin Liver Dis; 1997 May; 17(2):97-103. PubMed ID: 9170196 [TBL] [Abstract][Full Text] [Related]
39. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gordon SC; Quattrociocchi-Longe TM; Khan BA; Kodali VP; Chen J; Silverman AL; Kiechle FL Gastroenterology; 1995 Jun; 108(6):1802-9. PubMed ID: 7768386 [TBL] [Abstract][Full Text] [Related]
40. T cell immunity and primary biliary cirrhosis. Ishibashi H; Nakamura M; Shimoda S; Gershwin ME Autoimmun Rev; 2003 Jan; 2(1):19-24. PubMed ID: 12848971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]